Health

FDA Denies Autism Drug

The FDA has declined to approve a generic drug for autism, citing insufficient data. Instead, the drug was approved for a rare genetic condition. This decision raises questions about the FDA approval process and the availability of autism medication alternatives. The move is seen as a setback for families seeking affordable autism treatment options.